In this episode, Fidelia Bernice, PharmD, and Aadia I. Rana, MD, share insights on HIV ART safety and tolerability including recent data on nephrotoxicity and the use of NRTI-sparing regimens with discussion of the GEMINI-1 and -2 studies of DTG/3TC and the SWORD-1 and -2 studies of DTG/RPV, and safety with long-acting injectables with specific discussion of the ATLAS and FLAIR studies

Ursula Matulonis, MD
Program Director

Robert L. Coleman, MD, FACOG,
FACS
Physician – AMA - 11 Credit(s)
Advanced Practice Nurse – ANCC - 11 Credit(s)
Physician assistant – AAPA - 2.50 Hour(s)
Nurse – ANCC 1 Credit(s)